These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24127555)

  • 1. Genome-wide siRNA screen reveals a new cellular partner of NK cell receptor KIR2DL4: heparan sulfate directly modulates KIR2DL4-mediated responses.
    Brusilovsky M; Cordoba M; Rosental B; Hershkovitz O; Andrake MD; Pecherskaya A; Einarson MB; Zhou Y; Braiman A; Campbell KS; Porgador A
    J Immunol; 2013 Nov; 191(10):5256-67. PubMed ID: 24127555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Killer Ig-like receptor 2DL4 does not mediate NK cell IFN-γ responses to soluble HLA-G preparations.
    Le Page ME; Goodridge JP; John E; Christiansen FT; Witt CS
    J Immunol; 2014 Jan; 192(2):732-40. PubMed ID: 24337374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of NK cells by an endocytosed receptor for soluble HLA-G.
    Rajagopalan S; Bryceson YT; Kuppusamy SP; Geraghty DE; van der Meer A; Joosten I; Long EO
    PLoS Biol; 2006 Jan; 4(1):e9. PubMed ID: 16366734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitylation of an internalized killer cell Ig-like receptor by Triad3A disrupts sustained NF-κB signaling.
    Miah SM; Purdy AK; Rodin NB; MacFarlane AW; Oshinsky J; Alvarez-Arias DA; Campbell KS
    J Immunol; 2011 Mar; 186(5):2959-69. PubMed ID: 21270397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Killer Cell Ig-like Receptor 2DL4 Expression in Human Mast Cells and Its Potential Role in Breast Cancer Invasion.
    Ueshima C; Kataoka TR; Hirata M; Furuhata A; Suzuki E; Toi M; Tsuruyama T; Okayama Y; Haga H
    Cancer Immunol Res; 2015 Aug; 3(8):871-80. PubMed ID: 25735953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIR2DL4 differentially signals downstream functions in human NK cells through distinct structural modules.
    Miah SM; Hughes TL; Campbell KS
    J Immunol; 2008 Mar; 180(5):2922-32. PubMed ID: 18292514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNFR-associated factor 6 and TGF-β-activated kinase 1 control signals for a senescence response by an endosomal NK cell receptor.
    Rajagopalan S; Lee EC; DuPrie ML; Long EO
    J Immunol; 2014 Jan; 192(2):714-21. PubMed ID: 24337384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KIR2DL4 (CD158d): An activation receptor for HLA-G.
    Rajagopalan S; Long EO
    Front Immunol; 2012; 3():258. PubMed ID: 22934097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIR2DL4 (CD158d) genotype influences expression and function in NK cells.
    Goodridge JP; Witt CS; Christiansen FT; Warren HS
    J Immunol; 2003 Aug; 171(4):1768-74. PubMed ID: 12902476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells.
    Rajagopalan S; Long EO
    J Exp Med; 1999 Apr; 189(7):1093-100. PubMed ID: 10190900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killer Immunoglobulin-Like Receptor 2DL4 (CD158d) Regulates Human Mast Cells both Positively and Negatively: Possible Roles in Pregnancy and Cancer Metastasis.
    Kataoka TR; Ueshima C; Hirata M; Minamiguchi S; Haga H
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of HLA-G/KIR2DL4 in Breast Cancer Immune Microenvironment.
    Zheng G; Jia L; Yang AG
    Front Immunol; 2022; 13():791975. PubMed ID: 35185887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Genome-Wide CRISPR/Cas9-Based Screen Identifies Heparan Sulfate Proteoglycans as Ligands of Killer-Cell Immunoglobulin-Like Receptors.
    Klein K; Hölzemer A; Wang T; Kim TE; Dugan HL; Jost S; Altfeld M; Garcia-Beltran WF
    Front Immunol; 2021; 12():798235. PubMed ID: 34917099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endosomal signaling and a novel pathway defined by the natural killer receptor KIR2DL4 (CD158d).
    Rajagopalan S
    Traffic; 2010 Nov; 11(11):1381-90. PubMed ID: 20854369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residues Met76 and Gln79 in HLA-G alpha1 domain involve in KIR2DL4 recognition.
    Yan WH; Fan LA
    Cell Res; 2005 Mar; 15(3):176-82. PubMed ID: 15780179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comment on "Killer Ig-like receptor 2DL4 does not mediate NK Cell IFN-γ responses to soluble HLA-G preparations".
    Rajagopalan S; Long EO
    J Immunol; 2014 May; 192(9):4003. PubMed ID: 24748631
    [No Abstract]   [Full Text] [Related]  

  • 18. KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production.
    Kikuchi-Maki A; Yusa S; Catina TL; Campbell KS
    J Immunol; 2003 Oct; 171(7):3415-25. PubMed ID: 14500636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for balancing selection acting on KIR2DL4 genotypes in rhesus macaques of Indian origin.
    Blokhuis JH; van der Wiel MK; Doxiadis GG; Bontrop RE
    Immunogenetics; 2009 Jul; 61(7):503-12. PubMed ID: 19506858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to comment on "killer Ig-like receptor 2DL4 does not mediate NK cell IFN-γ responses to soluble HLA-G preparations".
    Le Page ME; Goodridge JP; John E; Christiansen FT; Witt CS
    J Immunol; 2014 May; 192(9):4003-4. PubMed ID: 24748632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.